J0791 Injection crizanlizumab-tmca 5mg
J-Codes
Also known as: Adakveo, crizanlizumab
Crizanlizumab-tmca monoclonal antibody injection supplied in 5 milligram units, a selective adhesion molecule inhibitor for vaso-occlusive crisis prevention.
Clinical Context
Used in adults with sickle cell disease to reduce the frequency of vaso-occlusive crises by inhibiting vascular adhesion of red blood cells.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.